NVUS stock forecast
Our latest prediction for Novus Therapeutics, Inc.'s stock price was made on the May 21, 2019 when the stock price was at 1.91$.
In the short term (2weeks), NVUS's stock price should outperform the market by 2.49%. During that period the price should oscillate between -11.09% and +23.85%.
In the medium term (3months), NVUS's stock price should outperform the market by 7.01%. During that period the price should oscillate between -22.81% and +55.95%.Get email alerts
About Novus Therapeutics, Inc.
Novus Therapeutics Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of products for disorders of the ear, nose, and throat. Its product pipelines include OPO201; OP0101; and OP0102. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.53$ per share.
The book value per share is 2.27$
Three months stock forecastMay 21, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|